David Rescott is Baird’s Senior Research Analyst covering Medical Technology. Prior to joining Baird in 2023, David served as an Equity Research Analyst covering U.S. Medical Supplies & Devices at Truist Securities and previously as an Associate. David also previously worked as an Associate covering Biomedical Devices and Services at Canaccord Genuity. David received a BS in Business Administration and French from State University of New York at Geneseo and a Master of Science in Finance from Vanderbilt University.